Biovie Valuation
BIVI Stock | USD 1.96 0.04 2.00% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Biovie Inc shows a prevailing Real Value of $2.72 per share. The current price of the firm is $1.96. Our model approximates the value of Biovie Inc from analyzing the firm fundamentals such as Shares Owned By Insiders of 13.69 %, return on equity of -2.08, and Current Valuation of 19.23 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Biovie's valuation include:
Undervalued
Today
Please note that Biovie's price fluctuation is very risky at this time. Calculation of the real value of Biovie Inc is based on 3 months time horizon. Increasing Biovie's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Biovie is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biovie Stock. However, Biovie's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 1.96 | Real 2.72 | Target 5.0 | Hype 1.89 | Naive 1.73 |
The intrinsic value of Biovie's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Biovie's stock price.
Estimating the potential upside or downside of Biovie Inc helps investors to forecast how Biovie stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biovie more accurately as focusing exclusively on Biovie's fundamentals will not take into account other important factors: When choosing an evaluation method for Biovie Inc, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Biovie Cash |
|
Biovie Valuation Trend
Biovie's real value analysis enables investors to forecast the earnings more efficiently. Using both Biovie's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Biovie Total Value Analysis
Biovie Inc is currently anticipated to have valuation of 19.23 M with market capitalization of 35.54 M, debt of 6.11 M, and cash on hands of 18.64 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Biovie fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
19.23 M | 35.54 M | 6.11 M | 18.64 M |
Biovie Asset Utilization
One of the ways to look at asset utilization of Biovie is to check how much profit was generated for every dollar of assets it reports. Biovie Inc shows a negative utilization of assets of -0.67 percent, losing $0.006669 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Biovie Inc shows how discouraging it operates for each dollar spent on its assets.Biovie Ownership Allocation
Biovie holds a total of 17.77 Million outstanding shares. Biovie Inc shows 13.69 percent of its outstanding shares held by insiders and 9.98 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Biovie Profitability Analysis
Net Loss for the year was (32.12 M) with profit before overhead, payroll, taxes, and interest of 0.About Biovie Valuation
An absolute valuation paradigm, as applied to Biovie Stock, attempts to find the value of Biovie Inc based on its fundamental and basic technical indicators. By analyzing Biovie's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Biovie's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biovie. We calculate exposure to Biovie's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biovie's related companies.Last Reported | Projected for Next Year | ||
Gross Profit | -206.4 K | -216.8 K |
Biovie Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 4.5 M |
Biovie Current Valuation Indicators
Valuation refers to the process of determining the present value of Biovie Inc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Biovie we look at many different elements of the entity such as Biovie's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Biovie, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Biovie's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Biovie's worth.Complementary Tools for Biovie Stock analysis
When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |